Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing nisoldipine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nisoldipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nisoldipine 10mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nisoldipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nisoldipine 20mg m/r tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nisoldipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nisoldipine 30mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nisoldipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nisoldipine 40mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nisoldipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nisoldipine m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nisoldipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nisoldipine 40mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nisoldipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nisoldipine 10 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Nisoldipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nisoldipine 10 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Nisoldipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing nisoldipine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nisoldipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nisoldipine 20 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Nisoldipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nisoldipine 20 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Nisoldipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nisoldipine 30 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Nisoldipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nisoldipine 30 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Nisoldipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only nisoldipine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nisoldipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only nisoldipine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nisoldipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |